Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 1998

View Archived Issues

CombiChem and Icos announce drug discovery collaboration

Mitotix describes novel inhibitors of the CDK/cyclin complexes

NPY Y1 receptor ligands for eating and cardiovascular disorders

New COX-2-selective compounds in development at Merck Frosst

Novel GH secretagogues disclosed by Novo Nordisk

MS&D describes novel class of antimigraine agents

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

Flk-1/KDR receptor tyrosine kinase inhibitor SU-5416 characterized at ACS meeting

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

VIMRx and Columbia U. form new drug discovery and development company

Interneuron receives fast track designation for CerAxon

TNFR:Fc evaluated clinically for congestive heart failure

Cytovia raises USD 10 million for development and commercialization of proprietary technology

Pharmacokinetic/safety results reported from ongoing phase I trial of Spartaject busulfan

Cyclic depsipeptide from Streptomyces induces apoptosis in tumor cells

Klinge identifies new apoptosis inducers active against MDR cell lines

Chinese scientists discover novel antitumor antibiotic

Hokuriku Seiyaku seeks development partners for novel antihistamine

New cell therapy developed at Wistar Institute shows potential as chemotherapy adjuvant

PKCbeta inhibitor from Lilly may potentiate effects of radio- and chemotherapy

Mechanism of cytotoxic effect of ImmTher

Aplidine evaluated for activity in animal models of lymphoma, prostate and gastric cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...